Newell, Felicity
Kong, Yan
Wilmott, James S.
Johansson, Peter A.
Ferguson, Peter M. http://orcid.org/0000-0002-8335-0406
Cui, Chuanliang
Li, Zhongwu
Kazakoff, Stephen H.
Burke, Hazel
Dodds, Tristan J.
Patch, Ann-Marie http://orcid.org/0000-0001-6121-4019
Nones, Katia
Tembe, Varsha
Shang, Ping
van der Weyden, Louise
Wong, Kim http://orcid.org/0000-0002-0984-1477
Holmes, Oliver
Lo, Serigne http://orcid.org/0000-0001-5092-5544
Leonard, Conrad
Wood, Scott
Xu, Qinying
Rawson, Robert V.
Mukhopadhyay, Pamela
Dummer, Reinhard
Levesque, Mitchell P.
Jönsson, Göran
Wang, Xuan
Yeh, Iwei
Wu, Hong
Joseph, Nancy
Bastian, Boris C. http://orcid.org/0000-0003-1836-6062
Long, Georgina V.
Spillane, Andrew J.
Shannon, Kerwin F.
Thompson, John F. http://orcid.org/0000-0002-2816-2496
Saw, Robyn P. M.
Adams, David J.
Si, Lu
Pearson, John V.
Hayward, Nicholas K.
Waddell, Nicola
Mann, Graham J.
Guo, Jun
Scolyer, Richard A. http://orcid.org/0000-0002-8991-0013
Article History
Received: 6 December 2018
Accepted: 18 June 2019
First Online: 18 July 2019
Competing interests
: J.V.P. and N.W. are founders and shareholders of genomiQa Pty Ltd, and members of its Board. B.C.B. is a Consultant to Lilly Inc. D.J.A. is a paid consultant for Microbiotica and receives research funding support from OpenTargets and BMS. None of these relationships involve the work described in this manuscript. R.D. has intermittent, project focused consulting and/or advisory relationships with Novartis, Merck Sharp & Dhome (MSD), Bristol-Myers Squibb (BMS), Roche, Amgen, Takeda, Pierre Fabre, Sun Pharma, Sanofi outside the submitted work. J.G. is consultant of MSD, Novartis, Pfizer and Bayer. J.F.T. is a Scientific Advisory Board member for GlaxoSmithKline, BMS, MSD Australia, and Provectus Inc. R.A.S. is a Scientific Advisor, Board Member for Merck Sharp & Dhome (MSD) and Novartis. None of these relationships involve the work described in this manuscript. The remaining authors declare no competing interests.